Source:http://linkedlifedata.com/resource/pubmed/id/20819887
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-9-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1468-5833
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
341
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
c4805
|
pubmed:meshHeading |
pubmed-meshheading:20819887-Cardiovascular Diseases,
pubmed-meshheading:20819887-Diabetes Mellitus, Type 2,
pubmed-meshheading:20819887-Drug Approval,
pubmed-meshheading:20819887-Humans,
pubmed-meshheading:20819887-Hypoglycemic Agents,
pubmed-meshheading:20819887-Safety-Based Drug Withdrawals,
pubmed-meshheading:20819887-Thiazolidinediones
|
pubmed:year |
2010
|
pubmed:articleTitle |
Licensing drugs for diabetes.
|
pubmed:publicationType |
Editorial
|